Aug 23, 2024 · Invega Sustenna is an extended-release antipsychotic medicine given by intramuscular injection. Invega Sustenna is prescription medicine used to treat schizophrenia in adults. Invega …

INVEGA HAFYERA® (paliperidone palmitate), a 6-month injection, is indicated for the treatment of schizophrenia in patients after they have been adequately treated with either INVEGA SUSTENNA® …

Dec 12, 2024 · Overview: Invega Sustenna is used to treat schizophrenia and schizoaffective disorder. It is a long-acting injection given once a month into a muscle by a health care provider.

INVEGA SUSTENNA® is available as a white to off-white aqueous extended-release injectable suspension for intramuscular injection in dose strengths of 39 mg, 78 mg, 117 mg, 156 mg, and 234...

May 9, 2025 · A summary of dosage and administration information for INVEGA SUSTENNA® (paliperidone palmitate 1-month)

Since paliperidone (the ingredient in Invega Sustenna) is a compound resulting from the breakdown of risperidone in the human body, any side effects that may occur after taking risperidone may also …

May 9, 2023 · INVEGA SUSTENNA® is given as an injection by your healthcare provider into the muscle (intramuscularly) of your arm or your buttocks. When you receive your first dose of INVEGA …

Feb 14, 2025 · Detailed dosage guidelines and administration information for Invega Sustenna (paliperidone palmitate). Includes dose adjustments, warnings and precautions.

See the step-by-step instructions for administering INVEGA SUSTENNA® (paliperidone palmitate) to adults with schizophrenia. See full Prescribing and Safety Info, including Boxed WARNING.

Jan 13, 2026 · A summary of dosage and administration information for INVEGA SUSTENNA® (paliperidone palmitate 1-month).